Project ECHO® Ontario: Epilepsy Across the Lifespan is a technology-enabled, collaborative, Continuing Professional Development (CPD) accredited learning program that partners community health care providers and epilepsy specialists to enhance care for children, adolescents and adults living with epilepsy.

Recognizing limited access to neurology and other specialties, which support this often complex population, our epilepsy interdisciplinary team connects with providers in communities across Ontario via one-to-many videoconferencing for 90-minute “TeleECHO® sessions”, twice monthly. Sessions can be accessed from a smart device or laptop from anywhere with an internet connection. The format of the TeleECHO® session leverages interactive case-based learning followed. Through sharing evidence-informed knowledge an actionable care plan for patients are developed. The session closes with a quick 15 – 20 minute didactic talk delivering relevant clinical pearls on a topic of interest.

How to Enroll:
Continuing Professional Development credits are free and enrollment is easy.
Please visit our website at https://oen.echoontario.ca/ for more information or email epilepsy@echoontario.ca 

About Epilepsy in Ontario
Epilepsy is second only to headache amongst common neurological conditions in Ontario, but the burden of illness of epilepsy is far greater. Epilepsy impacts approximately 90,000 Ontarians and 6,000 new cases of epilepsy diagnosed each year. Epilepsy can have a significant impact on quality of life. People with epilepsy are 71% more likely to have a concurrent mental health disorder in their lifetime. Many individuals with epilepsy, when diagnosed appropriately, can be treated effectively with antiepileptic drugs. An estimated 30% have drug-resistant epilepsy, experiencing seizures that do not respond to treatment with two or more appropriate trials of antiepileptic drug therapy. Other treatment options include surgery, diet therapy and neurostimulation.

COPYRIGHT © 2017 Project ECHO Ontario | Website Design by Inorbital Inc.